500 related articles for article (PubMed ID: 10722564)
21. Anthrax toxin: a tripartite lethal combination.
Ascenzi P; Visca P; Ippolito G; Spallarossa A; Bolognesi M; Montecucco C
FEBS Lett; 2002 Nov; 531(3):384-8. PubMed ID: 12435580
[TBL] [Abstract][Full Text] [Related]
22. Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies.
Brossier F; Lévy M; Landier A; Lafaye P; Mock M
Infect Immun; 2004 Nov; 72(11):6313-7. PubMed ID: 15501759
[TBL] [Abstract][Full Text] [Related]
23. Adenoviral Expression of a Bispecific VHH-Based Neutralizing Agent That Targets Protective Antigen Provides Prophylactic Protection from Anthrax in Mice.
Moayeri M; Tremblay JM; Debatis M; Dmitriev IP; Kashentseva EA; Yeh AJ; Cheung GY; Curiel DT; Leppla S; Shoemaker CB
Clin Vaccine Immunol; 2016 Jan; 23(3):213-8. PubMed ID: 26740390
[TBL] [Abstract][Full Text] [Related]
24. Anthrax lethal toxin (LeTx) neutralization by PA domain specific antisera.
Verma M; Suryanarayana N; Tuteja U; Thavachelvam K; Rao MK; Bhargava R; Shukla S
Toxicon; 2017 Dec; 139():58-65. PubMed ID: 28919458
[TBL] [Abstract][Full Text] [Related]
25. Molecular dynamics simulations of complexes between wild-type and mutant anthrax protective antigen variants and a model anthrax toxin receptor.
Stiles L; Nelson DJ
J Biomol Struct Dyn; 2005 Apr; 22(5):503-19. PubMed ID: 15702923
[TBL] [Abstract][Full Text] [Related]
26. Development of a novel chimeric PA-LF antigen of Bacillus anthracis, its immunological characterization and evaluation as a future vaccine candidate in mouse model.
Varshney A; Kumar M; Nagar DP; Pal V; Goel AK
Biologicals; 2019 Sep; 61():38-43. PubMed ID: 31416791
[TBL] [Abstract][Full Text] [Related]
27. Ratio of lethal and edema factors in rabbit systemic anthrax.
Molin FD; Fasanella A; Simonato M; Garofolo G; Montecucco C; Tonello F
Toxicon; 2008 Dec; 52(7):824-8. PubMed ID: 18812184
[TBL] [Abstract][Full Text] [Related]
28. Murine innate immune response to virulent toxigenic and nontoxigenic Bacillus anthracis strains.
Drysdale M; Olson G; Koehler TM; Lipscomb MF; Lyons CR
Infect Immun; 2007 Apr; 75(4):1757-64. PubMed ID: 17242059
[TBL] [Abstract][Full Text] [Related]
29. Lethal factor of anthrax toxin binds monomeric form of protective antigen.
Chvyrkova I; Zhang XC; Terzyan S
Biochem Biophys Res Commun; 2007 Aug; 360(3):690-5. PubMed ID: 17617379
[TBL] [Abstract][Full Text] [Related]
30. Proteome analysis of mouse macrophages treated with anthrax lethal toxin.
Chandra H; Gupta PK; Sharma K; Mattoo AR; Garg SK; Gade WN; Sirdeshmukh R; Maithal K; Singh Y
Biochim Biophys Acta; 2005 Mar; 1747(2):151-9. PubMed ID: 15698949
[TBL] [Abstract][Full Text] [Related]
31. Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthrax.
Lovchik JA; Drysdale M; Koehler TM; Hutt JA; Lyons CR
Infect Immun; 2012 Jul; 80(7):2414-25. PubMed ID: 22526673
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background.
Abboud N; Casadevall A
Clin Vaccine Immunol; 2008 Jul; 15(7):1115-23. PubMed ID: 18480236
[TBL] [Abstract][Full Text] [Related]
33. A bivalent protein r-PB, comprising PA and BclA immunodominant regions for comprehensive protection against Bacillus anthracis.
Majumder S; Das S; Somani V; Makam SS; Joseph KJ; Bhatnagar R
Sci Rep; 2018 May; 8(1):7242. PubMed ID: 29740033
[TBL] [Abstract][Full Text] [Related]
34. Protective antigen-mediated antibody response against a heterologous protein produced in vivo by Bacillus anthracis.
Brossier F; Weber-Levy M; Mock M; Sirard JC
Infect Immun; 2000 Oct; 68(10):5731-4. PubMed ID: 10992478
[TBL] [Abstract][Full Text] [Related]
35. Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R.
Zai X; Zhang J; Liu J; Liu J; Li L; Yin Y; Fu L; Xu J; Chen W
Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26927174
[TBL] [Abstract][Full Text] [Related]
36. Mapping the epitopes of a neutralizing antibody fragment directed against the lethal factor of Bacillus anthracis and cross-reacting with the homologous edema factor.
Thullier P; Avril A; Mathieu J; Behrens CK; Pellequer JL; Pelat T
PLoS One; 2013; 8(5):e65855. PubMed ID: 23741517
[TBL] [Abstract][Full Text] [Related]
37. Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity.
Turnbull PC; Leppla SH; Broster MG; Quinn CP; Melling J
Med Microbiol Immunol; 1988; 177(5):293-303. PubMed ID: 3139974
[TBL] [Abstract][Full Text] [Related]
38. Detoxified lethal toxin as a potential mucosal vaccine against anthrax.
Xu Q; Zeng M
Clin Vaccine Immunol; 2008 Apr; 15(4):612-6. PubMed ID: 18256208
[TBL] [Abstract][Full Text] [Related]
39. Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin.
Gaur R; Gupta PK; Banerjea AC; Singh Y
Vaccine; 2002 Jun; 20(21-22):2836-9. PubMed ID: 12034111
[TBL] [Abstract][Full Text] [Related]
40. Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.
Dumas EK; Gross T; Larabee J; Pate L; Cuthbertson H; Charlton S; Hallis B; Engler RJM; Collins LC; Spooner CE; Chen H; Ballard J; James JA; Farris AD
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
